Crowdfunding in Singapore raises RM10.11 million needed to buy drug to treat baby with rare genetic disorder


Baby Zayn was diagnosed with Type 1 spinal muscular atrophy about five weeks after he was born. - PHOTO: SYAHIRAH YAKUB

SINGAPORE, Nov 12 (The Straits Times/ANN): A five-month-old boy facing immobility or even death because of a rare genetic disorder may get a new lease on life after his parents successfully raised the S$3 million (RM10.11 million) needed to treat his condition.

Baby Zayn – who was diagnosed with Type 1 spinal muscular atrophy (SMA) about five weeks after he was born – will be able to get the drug Zolgensma by early December, his parents, Mr Nabeel Salim Abdat and Ms Syahirah Yakub, told The Sunday Times.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Aseanplus News

Johor exco line-up expected to be sworn in on July 17
Melaka Pakatan reaffirms decision to withdraw from state administration
Philippines VP Sara Duterte’s net satisfaction rating rises to 31 points: survey
Asean News Headlines at 10pm on Thursday (July 16, 2026)
Boko Haram exploited US and Chinese AI chatbots for attacks, Cambridge study finds
Construction sector issues new guidelines to implement total smoke ban in Hong Kong
Authorities order demolition of unauthorised buildings in northern Indian varsity
Lindsey Graham’s death removes one of Washington’s most influential China hawks
Singapore, Brunei reaffirm commitment to strengthening bilateral ties during SM Lee's visit
Korean man indicted for murdering girlfriend over argument

Others Also Read